Status:
COMPLETED
Modafinil for Wakefulness in the Critical Care Units
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Conditions:
Critical Illness
COVID-19
Eligibility:
All Genders
18-90 years
Brief Summary
It has been well documented that patients in the intensive care unit (ICU) are susceptible to developing neurocognitive and musculoskeletal complications because of various factors, including the natu...
Eligibility Criteria
Inclusion
- ICU patients 18 years and older
- admitted to COVID and non-COVID units between January 2017 and June 2020
- ICU stay for at least 48 hours
- started on modafinil during ICU stay for at least 48 h
- required ventilatory support.
Exclusion
- Those who did not receive modafinil or received modafinil for indications other than ICU wakefulness
Key Trial Info
Start Date :
November 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04751227
Start Date
November 22 2020
End Date
January 30 2021
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Specialist Hospital and Research Center
Riyadh, Saudi Arabia